tyrosine kinase inhibitor (TKI) therapyTKI therapycrizotinibbrigatinibbrain metastasesALK+ NSCLCALK-positive NSCLC
…ng ALK-positive NSCLC patients with brain metastases undergoing tyrosine kinase inhibitor (TKI) therapy. Quantitative radiomics (analyzing medical images beyond visual…